Vicarious Surgical (RBOT) Common Equity (2020 - 2025)

Vicarious Surgical (RBOT) has 6 years of Common Equity data on file, last reported at $9.8 million in Q4 2025.

• Quarterly Common Equity fell 78.93% year-over-year to $9.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $9.8 million (down 78.93% YoY) and the FY2025 annual result came in at $9.8 million, down 78.93% from the prior year.
• Common Equity fell to $9.8 million in Q4 2025 per RBOT's latest filing, from $14.1 million in the prior quarter.
• Across five years, Common Equity topped out at $129.8 million in Q2 2022 and bottomed at -$40.9 million in Q2 2021.
• The 5-year median for Common Equity is $73.8 million (2023), against an average of $62.7 million.
• The widest annual swing landed in 2022, when Common Equity surged 469.16%; it then slumped 78.93% in 2025.
• Tracing RBOT's Common Equity over 5 years: stood at $83.1 million in 2021, then soared by 33.64% to $111.0 million in 2022, then slipped by 11.78% to $98.0 million in 2023, then slumped by 52.33% to $46.7 million in 2024, then tumbled by 78.93% to $9.8 million in 2025.
• Per Business Quant, the three latest RBOT Common Equity figures stand at $9.8 million (Q4 2025), $14.1 million (Q3 2025), and $23.1 million (Q2 2025).

Peer Comparison